Emergent Biosolutions EBS Increase (Decrease) in Income Taxes Payable, Net of Income Taxes Receivable
Increase (Decrease) in Income Taxes Payable, Net of Income Taxes Receivable at other companies
Other financials
Where this comes from
Reported directly by Emergent Biosolutions in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable.
The official record: Emergent Biosolutions’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Emergent Biosolutions's increase (decrease) in income taxes payable, net of income taxes receivable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Emergent Biosolutions's increase (decrease) in income taxes payable, net of income taxes receivable?
- Emergent Biosolutions (EBS) reported increase (decrease) in income taxes payable, net of income taxes receivable of $4.6M in Q1 2026.
- How has Emergent Biosolutions's increase (decrease) in income taxes payable, net of income taxes receivable changed year-over-year?
- Emergent Biosolutions's increase (decrease) in income taxes payable, net of income taxes receivable increased by 154.8% year-over-year, from -$8.4M to $4.6M.
- What is the long-term trend for Emergent Biosolutions's increase (decrease) in income taxes payable, net of income taxes receivable?
- Over 2 years (2021 to 2023), Emergent Biosolutions's increase (decrease) in income taxes payable, net of income taxes receivable has grown at a -28.1% compound annual growth rate (CAGR), from -$31.3M to -$16.2M.